SCHEMBL19082264

SCHEMBL19082264

c1cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)cc(-c2c3sc4ccc5ccccc5c4c3cc3sc4ccccc4c23)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
PTPN1 P18031 1/20 0.33
ALOX5 P09917 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
DUSP3 P51452 1/20 0.33
BLM P54132 1/20 0.33
PTPN5 P54829 1/20 0.33
KMT2A Q03164 1/20 0.33
PTPN11 Q06124 1/20 0.33
MCL1 Q07820 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP1A1 P04798 1/20 0.31
CYP1B1 Q16678 1/20 0.31
CHEK1 O14757 1/20 0.31
WEE1 P30291 1/20 0.31
F9 P00740 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082257 0.94 ALOX5 (0.36) NQO1NQO2PTPN1ALOX5MEN1
SCHEMBL19082235 0.92 NQO2 (0.35) NQO1NQO2PTPN1MEN1POLB
SCHEMBL19082116 0.91 NQO1 (0.36) NQO1NQO2PTPN1ALOX5MEN1
SCHEMBL19082371 0.91 NQO1 (0.36) NQO1NQO2PTPN1ALOX5MEN1
SCHEMBL17944635 0.91 ALOX5 (0.38) NQO1NQO2PTPN1ALOX5MEN1
SCHEMBL19082310 0.90 NQO1 (0.34) NQO1NQO2PTPN1ALOX5MEN1
SCHEMBL19082276 0.89 ALOX5 (0.36) NQO1NQO2PTPN1ALOX5MAPT
SCHEMBL19082229 0.87 NQO2 (0.36) NQO1NQO2PTPN1ALOX5MEN1
SCHEMBL19077336 0.86 NQO2 (0.34) NQO1NQO2PTPN1ALOX5MEN1
SCHEMBL19082348 0.86 NQO2 (0.34) NQO1NQO2PTPN1MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 NQO1 576/4885NQO2 2592/4885PTPN1 4695/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 NQO1 576/4885NQO2 2592/4885PTPN1 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.